Position in UTHR
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,250
-$307 QoQ
Shares Held
6
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#832
of 870 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $94,449 across 13 Drug Manufacturers - Specialty & Generic names. UTHR ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHC |
Bausch Health Companies Inc.
|
8,553 | $42,166 | |
| 2 | ZTS |
Zoetis Inc.
|
200 | $14,372 | |
| 3 | VTRS |
Viatris Inc
|
617 | $9,797 | |
| 4 | HLN |
Haleon plc
|
1,017 | $9,488 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
62 | $6,878 | |
| 6 | CRDL |
Cardiol Therapeutics Inc.
|
5,000 | $5,300 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
6 | $3,250 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
85 | $2,879 |
All Filings in UTHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,250 | 6 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,557 | 6 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $2 | 6 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2 | 6 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1 | 6 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1 | 6 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $2,117 | 6 | Shares | Sole | 2025-01-24 | |
| No filing history on record for this holder in this stock. | ||||||